HDI Colon Cancer Detector
Colorectal Cancer
PreclinicalPlanned
Key Facts
About HT BioImaging
HT BioImaging delivers AI‑powered heat‑diffusion scans for rapid, point‑of‑care cancer detection in humans and animals.
View full company profileTherapeutic Areas
Other Colorectal Cancer Drugs
| Drug | Company | Phase |
|---|---|---|
| CY-101 + Pembrolizumab | Cytovation | Phase 1/2 |
| M9140 | Merck KGaA | Phase 1/2 |
| Repositioned/Rerouted API | Reponex | Not Specified |
| Leronlimab | CytoDyn | Phase 2 |
| EGFR inhibitor | Acellera | Pre-clinical |
| Cannabics® RCC-33 | CNBX Pharmaceuticals | Preclinical |
| VCR-036 | Vicero Bio | Preclinical |
| CBI-1214 | Cartography Biosciences | Phase 1 |
| QL335 | QLSF Biotherapeutics | Phase 1 |
| Colorectal Cancer Detection Partnership | Daisy Genomics | Research/Assay Development |
| High Internalization ADC | Lytica Therapeutics | Preclinical |
| Undisclosed Colorectal Program(s) | Tavanta Therapeutics | Phase 2 |